How Cochlear Implant Rehabilitation Impacts the Therapeutic Strategy for Vestibular Schwannoma

Francesco P Iannacone1, Francesca Visconti1, Elisabetta Zanoletti1

  • 1Department of Neuroscience DNS, Otolaryngology Section, University of Padova, 35100 Padova, Italy.

Audiology Research
|February 24, 2023
PubMed
Abstract

Insights

Cochlear implantation (CI) offers a promising solution for hearing rehabilitation in vestibular schwannoma (VS) patients, particularly those with small tumors and hearing loss or after failed hearing preservation surgery.

Area of Science:

  • Neurosurgery
  • Audiology
  • Otolaryngology

Background:

  • Vestibular schwannoma (VS) presents therapeutic challenges regarding functional morbidity, specifically facial nerve and hearing preservation.
  • Balancing tumor treatment with maintaining facial nerve function and hearing is a key clinical concern.

Purpose of the Study:

  • To evaluate the efficacy of cochlear implantation (CI) as a rehabilitation option for hearing loss in patients with vestibular schwannoma (VS).
  • To assess the role of CI in cases of compromised hearing or as a salvage strategy after hearing preservation surgery failure.

Main Methods:

  • A systematic literature review was conducted using PubMed and Scopus databases (2017-2022).
  • Fifteen articles were selected based on criteria including VS diagnosis (sporadic or NF2-related), cochlear implantation (simultaneous or sequential), and audiological outcomes with follow-up data.

Main Results:

  • Cochlear implantation demonstrates potential as a viable hearing rehabilitation strategy for VS patients.
  • The evidence level is currently low due to study design limitations and lack of treatment consensus.

Conclusions:

  • Cochlear implantation is a promising option for hearing rehabilitation in vestibular schwannoma patients.
  • It is particularly beneficial for small VS with pre-existing hearing deficits and as a salvage treatment post-hearing preservation surgery failure.

Related Concept Videos